Changeflow GovPing Healthcare & Life Sciences Regeneron EP4649500A1 Regulatory-Compliant Auto...
Routine Rule Added Final

Regeneron EP4649500A1 Regulatory-Compliant Automated Assay Systems Published April 2026

Favicon for changeflow.com EPO Patent Bulletin - Health Informatics (G16H)
Published
Detected
Email

Summary

The EPO published application EP4649500A1 titled "Systems and Methods for a Regulatory-Compliant Automated Assay" on April 15, 2026. Regeneron Pharmaceuticals, Inc. is the applicant, with inventors including Yi Liu Chen, Megan McCann, Owen Tang, Cuiping Zhao, Kristyn Greco, Rong Wang, and Keith Lawyer. The application is classified under G16H 20/40 and designates 31 European states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Health Informatics (G16H) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 69 changes logged to date.

What changed

The EPO published Regeneron Pharmaceuticals' patent application EP4649500A1 for automated assay systems designed for regulatory compliance. The application classifies under IPC G16H 20/40 and designates 31 European contracting states. Regeneron, a major biopharmaceutical company, filed this application covering systems and methods for regulatory-compliant automated assays.

For pharmaceutical and biotechnology firms, this publication establishes a priority date for Regeneron's regulatory-compliant assay technology and triggers the 18-month publication period before substantive examination. Competitors developing similar automated testing systems should review the claims upon grant to assess freedom-to-operate implications.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

SYSTEMS AND METHODS FOR A REGULATORY-COMPLIANT AUTOMATED ASSAY

Publication EP4649500A1 Kind: A1 Apr 15, 2026

Applicants

Regeneron Pharmaceuticals, Inc.

Inventors

CHEN, Yi Liu, MCCANN, Megan, TANG, Owen, ZHAO, Cuiping, GRECO, Kristyn, WANG, Rong, LAWYER, Keith

IPC Classifications

G16H 20/40 20180101AFI20240719BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Health Informatics (G16H)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Rule
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies Manufacturers
Industry sector
3254.1 Biotechnology
Activity scope
Patent publication IP filing Assay systems development
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when EPO Patent Bulletin - Health Informatics (G16H) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!